These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23086458)

  • 1. Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations.
    Shi C; Yu R; Shao S; Li Y
    J Mol Model; 2013 Feb; 19(2):871-8. PubMed ID: 23086458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants for interaction of partial agonists with acetylcholine binding protein and neuronal alpha7 nicotinic acetylcholine receptor.
    Hibbs RE; Sulzenbacher G; Shi J; Talley TT; Conrod S; Kem WR; Taylor P; Marchot P; Bourne Y
    EMBO J; 2009 Oct; 28(19):3040-51. PubMed ID: 19696737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the binding energy profiles of full agonists, partial agonists, and antagonists of the α7 nicotinic acetylcholine receptor.
    Tabassum N; Ma Q; Wu G; Jiang T; Yu R
    J Mol Model; 2017 Sep; 23(9):251. PubMed ID: 28770361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
    Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
    J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docking studies of benzylidene anabaseine interactions with α7 nicotinic acetylcholine receptor (nAChR) and acetylcholine binding proteins (AChBPs): application to the design of related α7 selective ligands.
    Kombo DC; Mazurov A; Tallapragada K; Hammond PS; Chewning J; Hauser TA; Vasquez-Valdivieso M; Yohannes D; Talley TT; Taylor P; Caldwell WS
    Eur J Med Chem; 2011 Nov; 46(11):5625-35. PubMed ID: 21986237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
    Papke RL; Schiff HC; Jack BA; Horenstein NA
    Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple interaction regions in the orthosteric ligand binding domain of the α7 neuronal nicotinic acetylcholine receptor.
    Xiao Y; Hammond PS; Mazurov AA; Yohannes D
    J Chem Inf Model; 2012 Nov; 52(11):3064-73. PubMed ID: 23092444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor.
    Gu RX; Gu H; Xie ZY; Wang JF; Arias HR; Wei DQ; Chou KC
    Med Chem; 2009 May; 5(3):250-62. PubMed ID: 19442215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes.
    Arias HR; Feuerbach D; Targowska-Duda K; Kaczor AA; Poso A; Jozwiak K
    Biochim Biophys Acta; 2015 Feb; 1848(2):731-41. PubMed ID: 25475645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidacloprid and thiacloprid neonicotinoids bind more favourably to cockroach than to honeybee α6 nicotinic acetylcholine receptor: insights from computational studies.
    Selvam B; Graton J; Laurent AD; Alamiddine Z; Mathé-Allainmat M; Lebreton J; Coqueret O; Olivier C; Thany SH; Le Questel JY
    J Mol Graph Model; 2015 Feb; 55():1-12. PubMed ID: 25424654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration.
    Kem WR; Mahnir VM; Prokai L; Papke RL; Cao X; LeFrancois S; Wildeboer K; Prokai-Tatrai K; Porter-Papke J; Soti F
    Mol Pharmacol; 2004 Jan; 65(1):56-67. PubMed ID: 14722237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals.
    Callahan PM; Bertrand D; Bertrand S; Plagenhoef MR; Terry AV
    Neuropharmacology; 2017 May; 117():422-433. PubMed ID: 28259598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of benzylidene-anabaseine analogues with agonist and allosteric sites on muscle nicotinic acetylcholine receptors.
    Arias HR; Xing H; Macdougall K; Blanton MP; Soti F; Kem WR
    Br J Pharmacol; 2009 May; 157(2):320-30. PubMed ID: 19338581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.
    Ulens C; Akdemir A; Jongejan A; van Elk R; Bertrand S; Perrakis A; Leurs R; Smit AB; Sixma TK; Bertrand D; de Esch IJ
    J Med Chem; 2009 Apr; 52(8):2372-83. PubMed ID: 19331415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
    Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
    Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and expression of human alpha7 nicotinic acetylcholine receptor extracellular domain mutants with enhanced solubility and ligand-binding properties.
    Zouridakis M; Zisimopoulou P; Eliopoulos E; Poulas K; Tzartos SJ
    Biochim Biophys Acta; 2009 Feb; 1794(2):355-66. PubMed ID: 19059502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding orientation of epibatidine at α7 nACh receptors.
    Thompson AJ; Metzger S; Lochner M; Ruepp MD
    Neuropharmacology; 2017 Apr; 116():421-428. PubMed ID: 28089847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric Agonism of
    Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
    Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors.
    Horenstein NA; McCormack TJ; Stokes C; Ren K; Papke RL
    J Biol Chem; 2007 Feb; 282(8):5899-909. PubMed ID: 17189260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.